Changeflow GovPing Pharma & Healthcare Early Pregnancy Behavioral Patterns and Gestati...
Routine Notice Added Final

Early Pregnancy Behavioral Patterns and Gestational Diabetes Risk

Favicon for changeflow.com ClinicalTrials.gov Studies
Published
Detected
Email

Summary

NIH ClinicalTrials.gov has registered a prospective nested randomized pilot trial (NCT07534670) examining how early-pregnancy chronobehavioral patterns including sleep irregularity, physical activity, and meal timing influence continuous glucose dynamics and gestational diabetes mellitus risk. The TOFFFY substudy at KK Women's and Children's Hospital, Singapore will enroll 140 pregnant women without pre-existing diabetes at 13 weeks gestation or less.

Published by NIH on changeflow.com . Detected, standardized, and enriched by GovPing. Review our methodology and editorial standards .

What changed

NIH ClinicalTrials.gov posted a clinical trial registration for a prospective nested randomized pilot study embedded within the TOFFFY cohort (NCT06293235) investigating the relationship between early pregnancy behavioral patterns and glucose dynamics. The trial will randomize 140 pregnant women without pre-existing diabetes to wearable-based self-monitoring (pilot arm) or usual care (control arm) to assess whether continuous glucose monitoring, wrist actigraphy, and AI-based meal timing logging can predict metabolic outcomes and gestational diabetes risk.

For compliance officers and clinical researchers, this registry entry documents an upcoming study utilizing continuous glucose monitoring devices, wearable actigraphy technology, and mobile health applications in a pregnancy research context. The trial conditions include gestational diabetes mellitus, circadian rhythm assessment, and metabolic disease monitoring, with an anticipated completion date of April 16, 2026.

Archived snapshot

Apr 16, 2026

GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.

← ClinicalTrials.gov Studies

Early Pregnancy Lifestyle and Glucose Patterns: A Substudy of TOFFFY

N/A NCT07534670 Kind: NA Apr 16, 2026

Abstract

The goal of this clinical trial is to examine how daily behavioral patterns in early pregnancy, including sleep, physical activity, and meal timing, influence continuous glucose dynamics and subsequent risk of gestational diabetes mellitus (GDM) in pregnant women without pre-existing diabetes.

The main questions it aims to answer are:

  1. Do early-pregnancy chronobehavioral patterns (e.g., irregular sleep, night eating, and unstable rest-activity rhythms) relate to continuous glucose patterns measured using continuous glucose monitoring (CGM)?
  2. Can early behavioral and CGM-derived measures predict glucose regulation and metabolic outcomes later in pregnancy (24-28 weeks)?
  3. Does real-time self-monitoring using wearable devices and food logging improve glycemic outcomes compared to usual care?

This study is a prospective, nested randomized pilot trial embedded within the ongoing Towards Optimal Fertility, Fathering and Fatherhood studY (TOFFFY) cohort (NCT06293235) at KK Women's and Children's Hospital, Singapore. A total of 140 pregnant women without pre-existing diabetes, recruited at ≤13 weeks gestation, will be randomized in a 1:1 ratio to either a pilot arm (wearable-based self-monitoring) or a control arm (usual care).

Participants in the pilot arm (n=70) will undergo intensive behavioral and metabolic monitoring over a 14-day period in early pregnancy, including continuous glucose monitoring using a CGM device, wrist actigraphy to assess sleep-wake and rest-act...

Conditions: Continuous Glucose Monitoring, Diabetes, Gestational, Diet During Pregnancy, Meal Time, Actigraphy, Pregnancy, Glucose Intolerance During Pregnancy, Gestational Diabetes Mellitus in Pregnancy, Circadian Rhythm, Sleep, Chronobiology, Wearable Electronic Devices, Mobile Applications, Blood Glucose Profile, Metabolic Diseases, Randomized Controlled Trial, Pilot Study

Interventions: Continuous glucose monitor (CGM), Wrist actigraphy device, AI-based dietary and meal timing logging mobile application

View original document →

Get daily alerts for ClinicalTrials.gov Studies

Daily digest delivered to your inbox.

Free. Unsubscribe anytime.

About this page

What is GovPing?

Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission

What's from the agency?

Source document text, dates, docket IDs, and authority are extracted directly from NIH.

What's AI-generated?

The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.

Last updated

Classification

Agency
NIH
Published
April 16th, 2026
Instrument
Notice
Legal weight
Non-binding
Stage
Final
Change scope
Minor
Document ID
NCT07534670

Who this affects

Applies to
Clinical investigators Healthcare providers Patients
Industry sector
6211 Healthcare Providers 3345 Medical Device Manufacturing
Activity scope
Clinical trial registration Research participant enrollment Metabolic monitoring
Geographic scope
United States US

Taxonomy

Primary area
Healthcare
Operational domain
Clinical Operations
Topics
Public Health Medical Devices

Get alerts for this source

We'll email you when ClinicalTrials.gov Studies publishes new changes.

Free. Unsubscribe anytime.

You're subscribed!